<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D11EB4D-13FC-420F-938D-A6A8015987BD"><gtr:id>2D11EB4D-13FC-420F-938D-A6A8015987BD</gtr:id><gtr:name>Clarity Biosolutions Limited</gtr:name><gtr:address><gtr:line1>Building 115
Porton Down Science Park
Porton Down</gtr:line1><gtr:city>Salisbury</gtr:city><gtr:postCode>SP4 0JQ</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>UNITED KINGDOM</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D11EB4D-13FC-420F-938D-A6A8015987BD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>2D11EB4D-13FC-420F-938D-A6A8015987BD</gtr:id><gtr:name>Clarity Biosolutions Limited</gtr:name><gtr:address><gtr:line1>Building 115
Porton Down Science Park
Porton Down</gtr:line1><gtr:city>Salisbury</gtr:city><gtr:postCode>SP4 0JQ</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>UNITED KINGDOM</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>34994.0</gtr:offerGrant><gtr:projectCost>49992.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6E750E7A-C076-435E-8AB0-484F65D6C7AD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>6E750E7A-C076-435E-8AB0-484F65D6C7AD</gtr:id><gtr:name>Kingston University</gtr:name><gtr:address><gtr:line1>River House</gtr:line1><gtr:line2>53-57 High Street</gtr:line2><gtr:line4>Kingston Upon Thames</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>KT1 1LQ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>49443.0</gtr:offerGrant><gtr:projectCost>49443.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/952038FA-C2F9-4BB8-9A06-DA09428DBBCA"><gtr:id>952038FA-C2F9-4BB8-9A06-DA09428DBBCA</gtr:id><gtr:firstName>Hugh</gtr:firstName><gtr:surname>Ballantine Dykes</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=133103"><gtr:id>641D611F-8AEA-4C7F-91DA-1DB1759EE781</gtr:id><gtr:title>Development of a rapid, point of care screening test for Staphylococcus aureus for acute patient admissions</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>133103</gtr:grantReference><gtr:abstractText>Modified Screening Guidance provided to the NHS removes the mandatory element of screening for MRSA. Commentary on the proposal from 4 hospital infection control groups suggest change away from universal screening can be expected to lead to a greater number of undetected MRSA patients, with a potentially greater transmission risk. This project develops Kingston University?s patent-pending fluorescence probe (LGX) that can detect SA at low bacterial concentration within 30 minutes, without the need for microbiological culturing and at a reduced cost. It will develop the technology from a bench test to a prototype assay validated by means of a clinical/usability study.</gtr:abstractText><gtr:fund><gtr:end>2018-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2017-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>84437</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">133103</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>